🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

Marinomed Biotech AG (MARI)

Vienna
Currency in EUR
8.00
-0.30(-3.61%)
Delayed Data
MARI Scorecard
Full Analysis
Operates with a significant debt burden
Fair Value
Day's Range
8.008.30
52 wk Range
2.0039.20
Bid/Ask
3.00 / 8.84
Prev. Close
8.3
Open
8.3
Day's Range
8-8.3
52 wk Range
2-39.2
Volume
685
Average Volume (3m)
3,499
1-Year Change
-77.81%
Fair Value
Unlock
Fair Value Upside
Unlock
MARI Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
63.00
Upside
+687.50%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Marinomed Biotech AG Company Profile

Marinomed Biotech AG, a biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally. The company operates through Virology, Immunology, and Other segments. Its products pipeline includes Budesolv for the treatment of allergic rhinitis; Tacrosolv, which is in Phase II clinical trial for inflammatory eye diseases; Carravin for the treatment of nasal congestion; and Inhaleen for viral pneumonia, as well as Carragelose, which consists of nasal and throat sprays, and lozenges for treating viral respiratory infections. The company has a technology partnership with SPH Sine Pharmaceutical Laboratories Co. Ltd. The company was formerly known as Marinomed Biotechnologie GmbH and changed its name to Marinomed Biotech AG in June 2017. Marinomed Biotech AG was incorporated in 2006 and is headquartered in Korneuburg, Austria.

Employees
44
Market
Austria

Compare MARI to Peers and Sector

Metrics to compare
MARI
Peers
Sector
Relationship
P/E Ratio
−2.0x−5.9x−0.6x
PEG Ratio
-−0.020.00
Price/Book
−1.2x0.5x2.6x
Price / LTM Sales
2.1x1.9x3.2x
Upside (Analyst Target)
-72.4%48.6%
Fair Value Upside
Unlock9.3%7.0%Unlock

FAQ

What Is the Marinomed Biotech AG (MARI) Stock Price Today?

The Marinomed Biotech AG stock price today is 8.00

What Stock Exchange Does Marinomed Biotech AG Trade On?

Marinomed Biotech AG is listed and trades on the Vienna stock exchange.

What Is the Stock Symbol for Marinomed Biotech AG?

The stock symbol for Marinomed Biotech AG is "MARI."

What Is the Marinomed Biotech AG Market Cap?

As of today, Marinomed Biotech AG market cap is 14.07M.

What is Marinomed Biotech AG Earnings Per Share?

The Marinomed Biotech AG EPS is -4.48.

What Is the Next Marinomed Biotech AG Earnings Date?

Marinomed Biotech AG will release its next earnings report on 20 Nov 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.